Visualizing microtubule-dependent vasopressin type 2 receptor trafficking using a new high-affinity fluorescent vasopressin ligand

Endocrinology

Volumn 152, Issue 10, 2011, Pages 3893-3904

  Chen, Sylvia ^a   Webber, Matthew J ^a   Vilardaga, Jean Pierre ^a,b   Khatri, Ashok ^a   Brown, Dennis ^a   Ausiello, Dennis A ^a   Lin, Herbert Y ^a   Bouley, Richard ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; GREEN FLUORESCENT PROTEIN; TETRAMETHYLRHODAMINE; VASOPRESSIN; VASOPRESSIN V2 RECEPTOR;

ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; ENDOSOME; MICROTUBULE; MITOSIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ANIMALS; CYCLIC AMP; FLUORESCENT DYES; LIGANDS; LLC-PK1 CELLS; MICROTUBULES; PROTEIN TRANSPORT; RECEPTORS, VASOPRESSIN; SWINE; VASOPRESSINS;

EID: 80053152576     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-1049     Document Type: Article

References (66)

1. Birnbaumer M, Seibold A, Gilbert S, Ishido M, Barberis C, Antaramian A, Brabet P, Rosenthal W 1992 Molecular cloning of the receptor for human antidiuretic hormone. Nature 357:333-335
2. De Keyzer Y, Auzan C, Lenne F, Beldjord C, Thibonnier M, BertagnaX, Clauser E 1994 Cloning and characterization of the human V3 pituitary vasopressin receptor. FEBS Lett 356:215-220 (Pubitemid 24376975)
3. Kimura T, Tanizawa O, Mori K, Brownstein MJ, Okayama H 1992 Structure and expression of a human oxytocin receptor. Nature 356:526-529
4. Lolait SJ, O'Carroll AM, McBride OW, Konig M, Morel A, Brownstein MJ 1992 Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature 357:336-339
5. Morel A, O'Carroll AM, Brownstein MJ, Lolait SJ 1992 Molecular cloning and expression of a rat V1a arginine vasopressin receptor. Nature 356:523-526
6. Sugimoto T, Saito M, Mochizuki S, Watanabe Y, Hashimoto S, Kawashima H 1994 Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor. J Biol Chem 269:27088-27092
7. Fushimi K, Sasaki S, Marumo F 1997 Phosphorylation of serine 256 is required for cAMP-dependent regulatory exocytosis of the aquaporin- 2 water channel. J Biol Chem 272:14800-14804 (Pubitemid 27251748)
8. Nielsen S, Chou CL, Marples D, Christensen EI, Kishore BK, Knepper MA 1995 Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. Proc Natl Acad Sci USA 92:1013-1017
9. Sabolic I, Katsura T, Verbavatz JM, Brown D 1995 The AQP2 water channel: effect of vasopressin treatment, microtubule disruption, and distribution in neonatal rats. JMembrBiol [Erratum (1995)145:107-108]143:165-175
10. Yamamoto T, Sasaki S, Fushimi K, Kawasaki K, Yaoita E, Oota K, Hirata Y, Marumo F, Kihara I 1995 Localization and expression of a collecting duct water channel, aquaporin, in hydrated and dehydrated rats. Exp Nephrol 3:193-201
11. Bahnsen U, Oosting P, Swaab DF, Nahke P, Richter D, Schmale H 1992 A missense mutation in the vasopressin-neurophysin precursor gene cosegregates with human autosomal dominant neurohypophyseal diabetes insipidus. EMBO J 11:19-23
12. Rosenthal W, Seibold A, Antaramian A, Lonergan M, Arthus MF, Hendy GN, Birnbaumer M, Bichet DG 1992 Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature 359:233-235
13. Innamorati G, Sadeghi H, Birnbaumer M 1999 Phosphorylation and recycling kinetics of G protein-coupled receptors. J Recept Signal Transduct Res 19:315-326 (Pubitemid 29152191)
14. Innamorati G, Sadeghi H, Eberle AN, Birnbaumer M 1997 Phosphorylation of the V2 vasopressin receptor. J Biol Chem 272:2486-2492 (Pubitemid 27058540)
15. Barak LS, Oakley RH, Laporte SA, Caron MG 2001 Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus. Proc Natl Acad Sci USA 98:93-98 (Pubitemid 32095869)
16. Bowen-Pidgeon D, Innamorati G, Sadeghi HM, Birnbaumer M 2001 Arrestin effects on internalization of vasopressin receptors. Mol Pharmacol 59:1395-1401 (Pubitemid 32510103)
17. Bouley R, Sun TX, Chenard M, McLaughlin M, McKee M, Lin HY, Brown D, Ausiello DA 2003 Functional role of the NPxxY motif in internalization of the type 2 vasopressin receptor in LLC-PK1 cells. Am J Physiol Cell Physiol 285:C750-C762 (Pubitemid 37158799)
18. Pfeiffer R, Kirsch J, Fahrenholz F 1998 Agonist and antagonist-dependent internalization of the human vasopressin V2 receptor. Exp Cell Res 244:327-339 (Pubitemid 28480881)
19. Innamorati G, Le Gouill C, Balamotis M, Birnbaumer M 2001 The long and the short cycle. Alternative intracellular routes for trafficking of G-protein coupled receptors. J Biol Chem 276:13096-13103
20. Robben JH, Knoers NV, Deen PM 2004 Regulation of the vasopressin V2 receptor by vasopressin in polarized renal collecting duct cells. Mol Biol Cell 15:5693-5699 (Pubitemid 39564759)
21. Bouley R, Lin HY, Raychowdhury MK, Marshansky V, Brown D, Ausiello DA 2005 Downregulation of the vasopressin type 2 receptor after vasopressin-induced internalization: involvement of a lysosomal degradation pathway. Am J Physiol Cell Physiol 288:C1390-C1401 (Pubitemid 40991076)
22. Wilcke M, Johannes L, Galli T, Mayau V, Goud B, Salamero J 2000 Rab11 regulates the compartmentalization of early endosomes required for efficient transport from early endosomes to the trans-Golgi network. J Cell Biol 151:1207-1220
23. Yi X, Bouley R, Lin HY, Bechoua S, Sun TX, Del Re E, Shioda T, Raychowdhury MK, Lu HA, Abou-Samra AB, Brown D, Ausiello DA 2007 Alix (AIP1) is a vasopressin receptor (V2R)-interacting protein that increases lysosomal degradation of the V2R. Am J Physiol Renal Physiol 292:F1303-F1313 (Pubitemid 46701893)
24. Lutz W, Sanders M, Salisbury J, Kumar R 1990 Internalization of vasopressin analogs in kidney and smooth muscle cells: evidence for receptor-mediated endocytosis in cells withV2orV1receptors. Proc Natl Acad Sci USA 87:6507-6511
25. Manning M, Stoev S, Chini B, Durroux T, Mouillac B, Guillon G 2008 Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents. Prog Brain Res 170:473-512 (Pubitemid 352014896)
26. Mouillac B, Manning M, Durroux T 2008 Fluorescent agonists and antagonists for vasopressin/oxytocin G protein-coupled receptors: usefulness in ligand screening assays and receptor studies. Mini Rev Med Chem 8:996-1005
27. Buku A, Schwartz IL, Gazis D, Ma CL, Eggena P 1985 Synthesis and biological activities of a fluorescent photoaffinity analog of vasopressin. Endocrinology 117:196-200 (Pubitemid 15019865)
28. Eggena P, Ma CL, Lu MQ, Buku A 1990 A fluorescent analogue of hydrin 1: a new probe for vasotocin receptors. Am J Physiol 259:E524-F528
29. Kirk KL 1988 Binding and internalization of a fluorescent vasopressin analogue by collecting duct cells. Am J Physiol 255:C622-C632
30. Kirk KL, Buku A, Eggena P 1987 Cell specificity of vasopressin binding in renal collecting duct: computer-enhanced imaging of a fluorescent hormone analog. Proc Natl Acad Sci USA 84:6000-6004
31. Lutz WH, Londowski JM, Kumar R 1990 Synthesis and biological activity of a biotinylated vasopressin analog. Peptides 11:687-691 (Pubitemid 20289039)
32. Lutz W, Londowski JM, Sanders M, Salisbury J, Kumar R 1992 A vasopressin analog that binds but does not activate V1 or V2 vasopressin receptors is not internalized into cells that express V1 or V2 receptors. J Biol Chem 267:1109-1115
33. Lutz W, Sanders M, Salisbury J, Lolait S, O'Carroll AM, Kumar R 1993 Vasopressin receptor-mediated endocytosis in cells transfected with V1-type vasopressin receptors. Kidney Int 43:845-852 (Pubitemid 23105218)
34. Fahrenholz F, Gerstberger R 1989 Vasopressin receptor subtypes: autoradiographic localization of V1 vasopressin binding sites in rat brain and kidney. J Protein Chem 8:370-372 (Pubitemid 19211936)
35. Jans DA, Peters R, Zsigo J, Fahrenholz F 1989 The adenylate cyclase- coupled vasopressin V2-receptor is highly laterally mobile in membranes of LLC-PK1 renal epithelial cells at physiological temperature. EMBO J 8:2481-2488 (Pubitemid 19273329)
36. Pavo I, Jans DA, Peters R, Penke B, Fahrenholz F 1994 Lateral mobility of the antagonist-occupied V2 vasopressin receptor in membranes of renal epithelial cells. Biochim Biophys Acta 1223:240-246 (Pubitemid 24278284)
37. Brown D, Lydon J, McLaughlin M, Stuart-Tilley A, Tyszkowski R, Alper S 1996 Antigen retrieval in cryostat tissue sections and cultured cells by treatment with sodium dodecyl sulfate (SDS). Histochem Cell Biol 105:261-267 (Pubitemid 26113171)
38. Kimbrough Jr RD, Cash WD, Branda LA, Chan WY, Du Vigneaud V 1963 Synthesis and biological properties of 1-desamino-8-lysine-vasopressin. J Biol Chem 238:1411-1414
39. 3H]1-deamino-8-D-arginine vasopressin as a radioligand for vasopressin V2-receptors in rat kidney. Endocrinology 122:1328-1336
40. Ufer E, Postina R, Gorbulev V, Fahrenholz F 1995 An extracellular residue determines the agonist specificity of V2 vasopressin receptors. FEBS Lett 362:19-23
41. Bouley R, Pérodin J, Plante H, Rihakova L, Bernier SG, Maletínská L, Guillemette G, Escher E 1998 N- and C-terminal structure-activity study of angiotensin II on the angiotensin AT2 receptor. Eur J Pharmacol 343:323-331 (Pubitemid 28138617)
42. Pérodin J, Bouley R, Escher E, Assimomytis N, Magafa V, Manessi-Zoupa E, Theodoropoulos D, Cordopatis P 2000 Angiotensin II analogues with sulphur-containing side-chains in position 5. A structure-activity relationship study. Arzneimittelforschung 50:526-529 (Pubitemid 30418407)
43. Cash WD, Smith BL 1963 Synthesis and biological properties of 1-acetyl-8-lysine-vasopressin. J Biol Chem 238:994-997
44. Kovács GL, Liu B, Burbach JP, Van Ree JM, De Wied D 1989 N α-acetyl-[Arg8]vasopressin antagonizes the behavioral effect of [Cyt6]vasopressin-(5-9), but not of vasopressin. Eur J Pharmacol 161:27-35 (Pubitemid 19058844)
45. Liu B, Burbach JP 1989 N-acetyl-vasopressin- and N-acetyl-oxytocin-like substances: isolation and characterization in the rat neurointermediate pituitary and presence in the brain. J Neuroendocrinol 1:47-52
46. Czaplewski C, Kaźmierkiewicz R, Ciarkowski J 1998 Molecular modeling of the human vasopressin V2 receptor/agonist complex. J Comput Aided Mol Des 12:275-287 (Pubitemid 128510956)
47. Macion-Dazard R, Callahan N, Xu Z, Wu N, Thibonnier M, Shoham M 2006 Mapping the binding site of six nonpeptide antagonists to the human V2-renal vasopressin receptor. J Pharmacol Exp Ther 316:564-571 (Pubitemid 43130982)
48. Oksche A, Leder G, Valet S, Platzer M, Hasse K, Geist S, Krause G, Rosenthal A, Rosenthal W 2002 Variant amino acids in the extracellular loops of murine and human vasopressin V2 receptors account for differences in cell surface expression and ligand affinity. Mol Endocrinol 16:799-813 (Pubitemid 34297748)
49. Oakley RH, Laporte SA, Holt JA, Barak LS, Caron MG 1999 Association of β-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization. J Biol Chem 274:32248-32257
50. Oakley RH, Laporte SA, Holt JA, Caron MG, Barak LS 2000 Differential affinities of visual arrestin, β arrestin1, and β arrestin2 for G protein-coupled receptors delineate two major classes of receptors. J Biol Chem 275:17201-17210 (Pubitemid 30398969)
51. Charest PG, Bouvier M 2003 Palmitoylation of the V2 vasopressin receptor carboxyl tail enhances β-arrestin recruitment leading to efficient receptor endocytosis and ERK1/2 activation. J Biol Chem 278:41541-41551 (Pubitemid 37280984)
52. Robben JH, Kortenoeven ML, Sze M, Yae C, Milligan G, Oorschot VM, Klumperman J, Knoers NV, Deen PM 2009 Intracellular activation of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus by nonpeptide agonists. Proc Natl Acad Sci USA 106:12195-12200
53. Tohgo A, Choy EW, Gesty-Palmer D, Pierce KL, Laporte S, Oakley RH, Caron MG, Lefkowitz RJ, Luttrell LM 2003 The stability of the G protein-coupled receptor-β-arrestin interaction determines the mechanism and functional consequence of ERK activation. J Biol Chem 278:6258-6267 (Pubitemid 36800882)
54. Moore RH, Millman EE, Alpizar-Foster E, Dai W, Knoll BJ 2004 Rab11 regulates the recycling and lysosome targeting of β2-adrenergic receptors. J Cell Sci 117:3107-3117 (Pubitemid 39139898)
55. Bucci C, Thomsen P, Nicoziani P, McCarthy J, Van Deurs B 2000 Rab7: a key to lysosome biogenesis. Mol Biol Cell 11:467-480 (Pubitemid 30112158)
56. Conti F, Sertic S, Reversi A, Chini B 2009 Intracellular trafficking of the human oxytocin receptor: evidence of receptor recycling via a Rab4/Rab5 "short cycle." Am J Physiol Endocrinol Metab 296:E532-E542
57. Daro E, Van der Sluijs P, Galli T, Mellman I 1996 Rab4 and cellubrevin define different early endosome populations on the pathway of transferrin receptor recycling. Proc Natl Acad Sci USA 93:9559-9564 (Pubitemid 26296647)
58. McCaffrey MW, Bielli A, Cantalupo G, Mora S, Roberti V, Santillo M, Drummond F, Bucci C 2001 Rab4 affects both recycling and degradative endosomal trafficking. FEBS Lett 495:21-30 (Pubitemid 32367967)
59. Sheff DR, Daro EA, Hull M, Mellman I 1999 The receptor recycling pathway contains two distinct populations of early endosomes with different sorting functions. J Cell Biol 145:123-139 (Pubitemid 29177680)
60. Sönnichsen B, De Renzis S, Nielsen E, Rietdorf J, Zerial M 2000 Distinct membrane domains on endosomes in the recycling pathway visualized by multicolor imaging of Rab4, Rab5, and Rab11. J Cell Biol 149:901-914
61. Van der Sluijs P, Hull M, Webster P, Mâle P, Goud B, Mellman I 1992 The small GTP-binding protein rab4 controls an early sorting event on the endocytic pathway. Cell 70:729-740
62. Dale LB, Seachrist JL, Babwah AV, Ferguson SS 2004 Regulation of angiotensin II type 1A receptor intracellular retention, degradation, and recycling by Rab5, Rab7, and Rab11 GTPases. J Biol Chem 279:13110-13118 (Pubitemid 38445889)
63. Roosterman D, Kreuzer OJ, Brune N, Cottrell GS, Bunnett NW, Meyerhof W, Steinhoff M 2007 Agonist-induced endocytosis of rat somatostatin receptor 1. Endocrinology 148:1050-1058
64. McLauchlan H, Newell J, Morrice N, Osborne A, West M, Smythe E 1998 A novel role for Rab5-GDI in ligand sequestration into clathrin-coated pits. Curr Biol 8:34-45 (Pubitemid 28056252)
65. Huang J, Imamura T, Olefsky JM 2001 Insulin can regulate GLUT4 internalization by signaling to Rab5 and the motor protein dynein. Proc Natl Acad Sci USA 98:13084-13089 (Pubitemid 33051321)
66. Nielsen E, Severin F, Backer JM, Hyman AA, Zerial M 1999 Rab5 regulates motility of early endosomes on microtubules. Nat Cell Biol 1:376-382 (Pubitemid 129493581)